MRC — Mercator Medical SA Income Statement
0.000.00%
Last trade - 00:00
- PLN409.38m
- PLN247.05m
- PLN542.51m
- 38
- 68
- 41
- 44
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 420 | 540 | 1,834 | 1,727 | 543 |
Cost of Revenue | |||||
Gross Profit | 72.7 | 80 | 1,151 | 622 | 26.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 404 | 533 | 787 | 1,264 | 724 |
Operating Profit | 16.6 | 7.19 | 1,048 | 463 | -181 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.35 | 2.07 | 1,041 | 477 | -186 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.22 | -2.03 | 936 | 445 | -191 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.64 | -2.33 | 930 | 447 | -190 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 7.64 | -2.33 | 930 | 447 | -190 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.537 | -0.244 | 88.4 | 45.5 | -20 |
Dividends per Share |